Janelle Drouin-Ouellet (Former)
1 – 34 of 34
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(
- Contribution to journal › Article
-
Mark
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease
(
- Contribution to journal › Article
- 2021
-
Mark
A quantitative model of cellular decision making in direct neuronal reprogramming
(
- Contribution to journal › Article
-
Mark
Reprogramming human adult fibroblasts into GABAergic interneurons
(
- Contribution to journal › Article
-
Mark
Neural tube patterning : from a minimal model for rostrocaudal patterning toward an integrated 3D model
(
- Contribution to journal › Article
- 2019
-
Mark
Cell-based therapy for Parkinson's disease : A journey through decades toward the light side of the Force
(
- Contribution to journal › Article
-
Mark
Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons
(
- Contribution to journal › Article
- 2018
-
Mark
Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts
(
- Contribution to journal › Article
-
Mark
Dermal fibroblasts from patients with Parkinson's disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
(
- Contribution to journal › Article
- 2017
-
Mark
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons : What have we learned?
(
- Contribution to journal › Scientific review
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
- 2016
-
Mark
Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
-
Mark
Brain repair and reprogramming : the route to clinical translation
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
(
- Contribution to journal › Scientific review
-
Mark
The role of tau in the pathological process and clinical expression of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and blood-brain barrier impairments in Huntington's disease : Potential implications for its pathophysiology
(
- Contribution to journal › Article
-
Mark
Dopamine and Huntington's disease
(
- Contribution to journal › Article
-
Mark
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice
(
- Contribution to journal › Article
-
Mark
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
(
- Contribution to journal › Article
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease
(
- Contribution to journal › Scientific review
- 2013
-
Mark
The challenges of administering cell-based therapies to patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier
(
- Contribution to journal › Article
- 2012
-
Mark
Parkinson's Disease in a Dish : What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?
(
- Contribution to journal › Article
-
Mark
Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Inflammation and neurodegeneration : the story 'retolled'
(
- Contribution to journal › Article
-
Mark
MyD88 deficiency results in both cognitive and motor impairments in mice
(
- Contribution to journal › Article
- 2011
-
Mark
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
(
- Contribution to journal › Article
-
Mark
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
(
- Contribution to journal › Article
-
Mark
Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions
(
- Contribution to journal › Article
- 2009
-
Mark
Environmental toxins and Parkinson's disease : what have we learned from pesticide-induced animal models?
(
- Contribution to journal › Scientific review